Bimatoprost: Prostaglandin F2α Analog for Ophthalmic Use
Bimatoprost is a synthetic prostamide analog structurally related to prostaglandin F2α. It reduces intraocular pressure (IOP) by increasing the outflow of aqueous humor through both the trabecular meshwork (conventional) and uveoscleral (unconventional) pathways. Bimatoprost is one of the most effective single agents for lowering IOP in glaucoma.
Product Profile
| CAS Number | 155206-00-1 |
|---|---|
| Molecular Formula | C25H37NO4 |
| Appearance | White to off-white crystalline powder |
| Therapeutic Category | Ophthalmic Prostaglandin Analog / Antiglaucoma |
| Storage | Store at controlled room temperature |
Applications
Bimatoprost ophthalmic solution (0.01% and 0.03%) is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Applied as one drop to the affected eye(s) once daily in the evening, it typically achieves IOP reductions of 7–9 mmHg from baseline. Bimatoprost 0.03% solution is also approved under a separate indication for the treatment of hypotrichosis of the eyelashes, applied to the upper eyelid margin with a sterile applicator. The eyelash growth application is based on the observed side effect of increased lash length, thickness, and darkening during glaucoma treatment. Bimatoprost is also used in veterinary ophthalmology for glaucoma management in dogs.
Why Source from TCS
TCS supplies bimatoprost to pharmaceutical companies across Europe and globally. Flexible order quantities from development samples to commercial volumes. Contact us with your target market and project requirements for a tailored quotation.
FAQ
What information should be included in an inquiry for Bimatoprost 155206-00-1?
A useful inquiry normally includes the product name, target application, estimated quantity, destination market, and any specific documentation or packaging requests.
How is Bimatoprost 155206-00-1 usually evaluated for sourcing?
This product is positioned for pharmaceutical sourcing discussions covering development, pilot, or commercial demand, subject to the buyer confirming application scope, market, and document requirements.
What documentation and commercial points are commonly reviewed before buying Bimatoprost 155206-00-1?
For pharmaceutical API procurement, buyers commonly align on specification review, target market, batch or annual demand, packaging expectations, and the documentation package needed for the project.
Request a Quote
If your team already has a target application, estimated quantity, destination market, or documentation requirements, send those details so the commercial response can be prepared more efficiently.